EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 12 May 2022

Faster, more equitable access to medicines across Europe

Lars Fruergaard Jørgensen (Novo Nordisk) for The Economist

“Together, we need to create a framework for equity-based tiered pricing to ensure that the price of innovative medicines can vary between countries, depending on their economic level and ability to pay.” Says Lars Fruergaard Jørgensen, Novo Nordisk president and CEO, and EFPIA vice-president to The Economist.

There are significant differences in patients’ access to medicines across Europe. How quickly a patient can benefit from a new treatment is more likely to be based on where they live, rather than on what they need. Faster, more equitable access to medicines across Europe has become a key priority for the research-based pharma industry and policymakers alike.
Read more

News

EFPIA & Vaccines Europe’s considerations on the lessons learned from the COVID-19 pandemic...
11 May 2022

Since the onset of the COVID-19 pandemic, the research-based pharmaceutical industry has been committed to working collaboratively... Read more

Blogs

Meeting the diabetes challenge
12 May 2022 - Bart Torbeyns

EUDF ideas and solutions to enhance the quality of diabetes care, and to improve health outcomes and quality of life... Read more

Solutions for rapid and sustained patient access to precision medicine
12 May 2022 - Lieven Annemans

Both access to biomarker testing as well as access to precision-based therapies are inconsistent across Europe and contribute... Read more

European Health Data Space: Working together to overcome inequalities in the EU
11 May 2022 - Bartek Madej

Countries with greater skills, knowledge and capabilities will be able to share their wins with countries which have... Read more

Events

Towards a new normal: Why boosting cardiovascular health is critical
13 May 2022 (Virtual event)

Opportunities for healthcare systems to build back better for patients in Europe Read more

Maximise EHDS impact on better health data sharing
18 May 2022 (Hybrid in Brussels (Rue de l’Industrie 24, 1040 Brussels) and Online)

European Health Coalition Hybrid Workshop on the new European Health Data Space Proposal Read more

Faster, more equitable access to medicines across Europe
19 May 2022 (Virtual event)

How pharma and healthcare stakeholders can find collaborative solutions Read more

mportance of Diversity & Equal Opportunities in a Healthy R&D Environment - Workforce and Organizational...
02 June 2022 (June 2, 14:00-15:30 CET)

Workforce and Organizational Culture Read more

Join the EFPIA team!

We are hiring a Manager and a Senior Manager for our Public Affairs team. Read the full job description on our website.

What we are reading

The Neuronet Coordination and Support Action releases updated Decision Tool for engagement...
On 09 May 2022 (IMI)

Neuronet Decision Tool now provides a clickable overview of the processes and procedures for HTA and regulatory interactions... Read more

Patient Involvement in HTA in Europe: Stakeholder Experiences
On 03 May 2022 (EPF, HTAi, EUPATI)

EFP, HTAi and EUPATI invite HTA bodies, industry and patients to fill a survey on their HTA experience. Read more

Europe embraces real-world data
On 25 April 2022 (MedNous)

An interview with Álmath Spooner, Vice-Chair of EFPIA IEGU WG and an Observer to DARWIN EU Advisory Board. Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu